Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)

ClinicalTrials.gov ID: NCT06088290

Public ClinicalTrials.gov record NCT06088290. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 22, 2026, 10:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Controlled, Open-label, Phase III Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Patients With Metastatic Leiomyosarcoma

Study identification

NCT ID: NCT06088290
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: PharmaMar; Industry
Enrollment: 450 participants

Conditions and interventions

Conditions

Leiomyosarcoma

Interventions

Doxorubicin Drug
Lurbinectedin Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 20, 2023
Primary completion: Aug 29, 2029
Completion: Aug 29, 2029
Last update posted: Apr 16, 2026

2023 – 2029

United States locations

U.S. sites: 24
U.S. states: 16
U.S. cities: 21

Facility	City	State	ZIP	Site status
Mayo Clinic Hospital - Phoenix	Phoenix	Arizona	85054	Recruiting
Precision NextGen Oncology & Research Center	Beverly Hills	California	90212	Recruiting
Cedars-Sinai Medical Center	Los Angeles	California	90025	Not yet recruiting
Norris Comprehensive Cancer Center	Los Angeles	California	90033	Recruiting
Sarcoma Oncology Center	Los Angeles	California	90057	Recruiting
Stanford University (Leland Stanford Junior University)	Palo Alto	California	94304	Recruiting
University of Colorado Hospital - Anschutz Medical Campus	Aurora	Colorado	80045	Recruiting
Mayo Clinic - Jacksonville	Jacksonville	Florida	32224	Recruiting
Moffitt Cancer Center	Tampa	Florida	33612	Recruiting
Augusta University Georgia Cancer Center	Augusta	Georgia	30912	Recruiting
Massachusetts General Hospital	Boston	Massachusetts	02114	Recruiting
Dana-Farber Cancer Institute	Boston	Massachusetts	02215	Recruiting
University of Michigan	Ann Arbor	Michigan	48109	Recruiting
Mayo Clinic - Rochester	Rochester	Minnesota	55905	Recruiting
Washington University School of Medicine in St. Louis	St Louis	Missouri	63110	Recruiting
Memorial Sloan Kettering Cancer Center - New York	New York	New York	10065	Recruiting
Cleveland Clinic Main Campus	Cleveland	Ohio	44195	Completed
Oregon Health and Science University	Portland	Oregon	97239	Recruiting
University of Pennsylvania Abramson Cancer Center	Philadelphia	Pennsylvania	19104	Recruiting
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center	Pittsburgh	Pennsylvania	15232	Recruiting
Vanderbilt - Ingram Cancer Center	Nashville	Tennessee	37232	Recruiting
UT Southwestern Harold C. Simmons Comprehensive Cancer Center	Dallas	Texas	75390-8562	Recruiting
University of Texas MD Anderson Cancer Center	Houston	Texas	77030	Recruiting
Fred Hutchinson Cancer Center - Seattle Cancer Care Alliance (SCCA) Location	Seattle	Washington	98109	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06088290, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 16, 2026 · Synced Apr 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06088290 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →